Drug Topics
OCTOBER 22, 2024
A discussion with Madison Irwin, PharmD, BCPS, clinical pharmacist specialist in palliative care at University of Michigan Health and clinical assistant professor at the University of Michigan College of Pharmacy.
Pharmacy Times
OCTOBER 22, 2024
Comprising most cases of this rare form of lymphoma, it is essential that pharmacists and treatment providers are aware of the health-related burdens patients with these subtypes consistently face.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 22, 2024
Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make. Compounding pharmacies are typically allowed to make copies of drugs that are deemed to be in shortage by the FDA, which semaglutide has been for over two years.
Drug Topics
OCTOBER 22, 2024
Analyzing copayments and coverage plans for popular weight-loss drugs in the US, researchers addressed the cost-effectiveness of GLP-1 medications for treating obesity.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
OCTOBER 22, 2024
Senators led by Sen. Dick Durbin (D-Ill.) on Monday demanded answers from Pfizer and Eli Lilly about their relationship with the telehealth prescribers they point patients to from their websites, seeking to determine whether the pharma giants are violating the federal anti-kickback statute. This year, both Pfizer and Eli Lilly launched websites that allow users to learn about their medications, follow links to “talk to a doctor now,” and fill their prescriptions through an online p
Drug Topics
OCTOBER 22, 2024
Three posters showcased at IDWeek 2024 focused on enhancing access to HIV prevention and treatment, as well as increasing uptake of pre-exposure prophylaxis (PrEP) among women.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 22, 2024
There’s a fundamental barrier to scientific certainty in food science. People eat foods, not nutrients. The experts charged with advising federal health officials on the 2025-2030 Dietary Guidelines for Americans had to scale a mountain of research challenges like this basic impediment, starting with the impossibility of randomly assigning people to eat only x or y for 30 to 40 years.
Pharmacy Times
OCTOBER 22, 2024
New recommendations from the American Stroke Association (ASA) emphasize the importance of healthy lifestyle habits and addressing health equity to reduce stroke risk.
Fierce Pharma
OCTOBER 22, 2024
Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job. | Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job in a new presentation.
Pharmacy Times
OCTOBER 22, 2024
Pharmacists are positioned to combat the opioid crisis through educating the public and advocating for policy changes to enable harm reduction strategies.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 22, 2024
Ten years ago, neither Allyson Berent, Terry Pirovolakis nor Michelle Werner expected to be founders of biotech companies. But they’ve all done so with the goal of helping to treat their children’s rare diseases. The three parents took the stage at the 2024 STAT Summit to talk about the challenges of trying to find treatments for rare diseases — from securing funding to translating research in animals to humans to commercial barriers.
Drug Topics
OCTOBER 22, 2024
Posters presented at IDWeek 2024 provided new insights into the impact of COVID-19 infection and vaccination on women’s health.
Fierce Healthcare
OCTOBER 22, 2024
Amazon One Medical, working with the online retail company's technology teams, developed artificial intelligence tools for its clinicians to help them save time. | Amazon One Medical, working with the online retail company's technology teams, developed artificial intelligence tools for its clinicians to help them save time.
STAT
OCTOBER 22, 2024
Editas Medicine said Tuesday it will license out or partner its lead sickle cell treatment, the latest shift for a tarantella company that has repeatedly switched direction and leadership since first emerging as one of the first CRISPR biotechs a decade ago. Editas will now focus on a different, newly announced sickle cell program.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Pharma
OCTOBER 22, 2024
Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. | Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. The layoffs come three months after the company axed 150 positions in Sanford following a high-profile phase 3 trial failure for its Duchenne muscular dystrophy gene therapy candidate.
STAT
OCTOBER 22, 2024
Genetics can be cruel. Lawrence Ingrassia, a longtime journalist, has learned that the hard way. A genetic mutation that runs in his family predisposes those who carry it to developing malignant tumors of all types. It’s why, at age 69 and 30 days, he became the longest living member of his family.
pharmaphorum
OCTOBER 22, 2024
Otsuka is hoping to file for approval of its anti-APRIL antibody sibeprenlimab as a treatment for kidney disorder IgA nephropathy (IgAN) after the drug hit the target in a phase 3 trial.The Japanese drugmaker said that interim results from the 530-patient VISIONARY study showed that sibeprenlimab achieved a statistically significant and clinically meaningful reduction in 24-hour urine protein-to-creatine ratio (uPCR) – a measure of how well the kidneys are working – after nine months of treatmen
STAT
OCTOBER 22, 2024
Abortion restrictions spreading across the county have upended people’s ability to make decisions about their lives, families, and futures. While the overall number of abortions in the U.S. has gone up since the Dobbs decision, in large part due to the growth of telehealth abortion, those numbers don’t tell the stories of people who have to move heaven and earth to get this basic, essential health care.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
OCTOBER 22, 2024
Investigators conducted a study to assess the impact of combined diet and exercise interventions in patients with type 2 diabetes.
STAT
OCTOBER 22, 2024
Michelle Tarver will be the new leader of the medical devices center at the Food and Drug Administration, according to an email reviewed by STAT and sent out to FDA device staff on Tuesday afternoon. Tarver has temporarily served in the role since veteran devices head Jeffrey Shuren announced his departure in July. The agency conducted a nationwide search for Shuren’s replacement, but Tarver quickly seemed to be the top pick, shadowing Shuren at conferences and town halls.
Fierce Pharma
OCTOBER 22, 2024
With Johnson & Johnson sweetening the pot and mustering up the support of 83% of those who claim that the company’s talc products caused their cancer, it had
STAT
OCTOBER 22, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning. Check out the latest promo we’re running, where you can get your first three months of a STAT+ subscription for $20.
Fierce Healthcare
OCTOBER 22, 2024
LAS VEGAS — Longtime Humana CEO Bruce Broussard departed the company over the summer, and now he's made his next move. | LAS VEGAS — Longtime Humana CEO Bruce Broussard departed the company over the summer, and now he's made his next move.
pharmaphorum
OCTOBER 22, 2024
Sanofi is now in exclusive talks with private equity company Clayton Dubilier & Rice over the sale of a controlling stake in its consumer health business Opella, as the French government seeks guarantees it will keep production and jobs in France.
Fierce Healthcare
OCTOBER 22, 2024
In healthcare, the best solutions come from bringing different perspectives to the table. | This week on "Podnosis," we examine why diverse viewpoints are essential for tackling the industry’s toughest challenges and how building real engagement serves as the bedrock for innovation.
The Checkup by Singlecare
OCTOBER 22, 2024
You’ve probably heard the buzz about Ozempic (active ingredient semaglutide), a popular brand name, FDA-approved Type 2 diabetes medication that’s also used off-label for weight loss. Like Mounjaro , Saxenda , Zepbound , and Wegovy , the prescription medication belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists, or GLP-1 receptor agonists , that work by mimicking the effects of a hormone called GLP-1 to regulate blood sugar levels.
Fierce Pharma
OCTOBER 22, 2024
With multiple high-profile production pacts already in the books for 2024, CDMO Samsung Biologics has hooked another big one. | Following a string of high-profile deals, Samsung Biologics has locked down a $1.2 billion contract with an unnamed Asia-based pharmaceutical company that’s expected to run through December 2037. Samsung did not elaborate on the identity of its new partner or the types of drugs it will help produce under the accord.
pharmaphorum
OCTOBER 22, 2024
Discover the seven essential pillars of GenAI for generating value at an enterprise level and leveraging artificial intelligence to drive innovation and growth.
Pharmacy Times
OCTOBER 22, 2024
Endometriosis is a systemic disease that can affect multiple parts of the body, not just the pelvis.
Fierce Healthcare
OCTOBER 22, 2024
LAS VEGAS—Suki AI has inked a deal with the nation’s largest telehealth platform, Zoom Healthcare, to integrate an AI assistant into Zoom’s telehealth experience. | Suki will deploy its current AI assistant features like ambient scribe and clinical note generation and build out new technology to reimagine telehealthcare.
Pharmacy Times
OCTOBER 22, 2024
The FDA previously accepted the biologic license application for CT-P13 as a subcutaneous formulation.
STAT
OCTOBER 22, 2024
Good morning! There are two impending deadlines weighing on my mind this week: We’ve got exactly two weeks until the presidential election, and 12 days until daylight savings time ends here in Boston. Philly hospitals stop using race-adjusted algorithms A coalition of 12 Philadelphia-area health systems announced yesterday that its members have abandoned the use of race adjustments in four clinical tools commonly used to guide care, a move that health leaders say will improve treatment an
Fierce Pharma
OCTOBER 22, 2024
There’s no denying it: the radiopharmaceuticals boom is here to stay. | Telix on Tuesday unveiled the spin-off of Rhine Pharma—a new entity born from a collaboration between Telix and Germany’s Heidelberg University Hospital—which is setting out on a mission to expand access to radiopharmaceuticals for cancer treatment and imaging.
Expert insights. Personalized for you.
232 
Let's personalize your content